BACKGROUND AND AIMS
We compared the real-world effectiveness of advanced therapies (AT) in patients with ulcerative colitis (UC).
METHODS
Using the OptumLabs® Data Warehouse, a nationally representative US administrative claims database, we identified patients with UC initiating infliximab, adalimumab, vedolizumab, u...
M. Hupé, D. Ahuja, Kuan-Hung Yeh et al.· Clinical Gastroenterology an...· 0 citations
BACKGROUND & AIMS
Advanced therapies (ATs) are central to the management of moderate-to-severe ulcerative colitis (UC). The expanding therapeutic landscape and limited head-to-head trials necessitate updated comparative effectiveness analyses. We performed a systematic review and network meta-analysis (NMA) to assess t...
Pablo A. Olivera, Juan S. Lasa, Siddharth Singh et al.· Clinical Gastroenterology an...· 0 citations
BACKGROUND AND AIMS
We conducted a retrospective cohort study comparing the risk of cancer in patients with inflammatory bowel diseases (IBD) initiating advanced therapies (ATs).
METHODS
Using an administrative claims database (OptumLabs® Data Warehouse), we identified patients with IBD with no prior history of cance...
D. Ahuja, Kuan-Hung Yeh, Soo-kyung Park et al.· Clinical Gastroenterology an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.